Therapeutic potential of bone marrow (BM)-derived cells in acute and chronic liver injury model has been investigated. Apart from pathological improvement of the liver, we also studied liver regeneration and genetic alteration in donor cells towards neoplasia. Acetaminophen-induced acute and CCl4-induced chronic liver injured male mice were transplanted with BM-derived uncommitted and CD45 + cells, respectively from female mice. Transplantation of CD45 cells resulted in enhanced recovery of fibrotic liver during initial pro-fibrogenic condition as compared with sham control. Significant recovery from apoptotic death of hepatocytes was also observed. After 3 months of transplantation, donor-derived hepatocytes in acute and chronic liver injury models were found to be about 5% and 17%, respectively. Real-time RT-PCR analyses revealed that neither donor-derived hepatocytes nor recipient liver expressed pluripotency (Oct4, Nanog, Sox2) and α-fetoprotein (AFP) genes, a suppressive response of tumor-related Cyclin D2 was also seen. About 96% of the donor-derived hepatocytes were devoid of Sry gene and contain only XX chromosome. Thus, BMderived cells were found to be a potential therapeutic tool for the treatment of both acute and chronic liver diseases. Preliminary results suggested that post nuclear reprogramming of BM cells does not lead to activation of neoplastic genes.
regeneration remains low [1] [2] [3] [4] [5] . The first successful report was published in case of fumarylacetoacetate hydrolase knockout (Fah -/-) mouse model, in which dietary supplement 2-(2-Nitro-4-trimethylbenzoyl)-1,3-cyclohexadione (NTBC) was used to ameliorate liver damage. The recipient of wild type BM progenitor cells, following withdrawal of NTBC, showed not only phenotype correction, the liver nodules also exhibited 50-70% chimerism with donor-derived cells [6, 7] . It was shown than the newly formed hepatocytes, generated from the fused heterokaryons, can expand rapidly owing to a considerable survival advantage in the absence of NTBC [8, 9] . Despite inherent limitation of low contribution in liver regeneration, BM-derived cells have been used in many studies involving experimental animals and human subjects [10] [11] [12] . All these studies have focused on the feasibility of BM cell therapy to treat diseases like inborn metabolic disorders or liver cirrhosis [6, [13] [14] [15] [16] [17] [18] . It is not clearly understood whether BM cells are directly involved in regeneration of liver, though the paracrine effect of the same in activation of hepatic progenitor cells (HPCs) has been reported [19] . In this study we have adopted two experimental liver disease models. The rationale for choosing these models was that acute injury model resembles liver damage due to overdose of toxin, whereas chronic injury mimics liver damage due to prolonged inflammatory response. In case of liver failure, whole organ or hepatocytes transplantation has been limited due to global shortage of donor livers; hence an alternative therapeutic approach is warranted. Again, cell fusion leads to polyploidy and chromosomal instability, both considered to be the early events in carcinogenesis. Thus, it is important that the BM-derived hepatocytes be examined for such cellular changes, if any. Here we have addressed the following questions: a) does the phenotype change from hematopoietic to hepatic lineage results in the activation of genes that are associated with neoplastic changes, b) whether the host chromosome is completely segregated from the donor-derived hepatocytes after the cell fusion, and c) in case of chronic injury, can the donor cells also take part in regeneration of liver apart from the resolution of fibrosis.
Introduction
All major metabolic and synthesis functions of liver are significantly perturbed in case of critical injury. Though liver regenerates by itself following acute injury, this process is impaired in case of chronic injury. In both cases, unless liver is allowed to regenerate by proving appropriate support, either internally or externally, depending up on the extent of injury it ceases to function and transplantation remains the only available treatment option.
Adult BM-derived cells were found to contribute towards liver regeneration in irradiation-induced acute injury model, but due to inadequate selection pressure the involvement of these cells in liver DOI: 10.23937/2469-570X/1410034 ISSN: 2469-570X
Chennai, India) via intraperitoneal route. Chronic liver injury model was established by repeated injection (0.8 ml/kg body weight) of 10% CCl 4 (CDH, Mumbai, India) in mineral oil (Sigma-Aldrich, St. Louise), twice a week, for a period of 10 weeks via intraperitoneal route. Pro-fibrotic condition was maintained by CCl 4 injection (0.4 ml/kg body weight) for 15 days after transplantation of the cells.
The extent of liver injury was assessed by histopathology and sera ALT levels. The measurement of ALT activity was carried out using a commercially available kit (Transasia Bio-medicals Ltd, New Delhi, India). In brief, the rate of NADH oxidation was determined in a coupled reaction employing lactate dehydrogenase (LD). The oxidation of NADH to NAD + is accompanied by decrease in absorbance at 340 nm. In the sera samples where ALT is rate limiting, the decrease of absorbance is directly proportional to the activity of ALT. To determine the extent of liver fibrosis, 5-µm sections of formalin fixed liver of different time points, embedded in paraffin, were cut from different lobes (parallel sections were not considered). The sections were stained with hematoxylin (Sigma-Aldrich, Bangalore, India) followed by picrosirius red (Polyscience Inc., Warrington, PA). Finally, the collagen proportionate area (CPA) was measured using ImageJ software (NIH, Bethesda, MD) considering only the stained area. The activation status of HpSCs was examined by staining with α-smooth muscle actin (α-SMA) antibody, followed by determining the α-SMA area as explained above.
Transplantation of cells
Lin-BM cells were isolated from eGFP-expressing female C57Bl/6J mice following negative selection with MACS kit (Miltenyi Biotec, Gladbach, Germany). Two hundred fifty thousand Lin-BM cells were transplanted in each mouse in a group of 12 with acute liver injury through intravenous route and another 6 mice (sham control) received normal saline. For isolation of CD45 + cells, mononuclear BM cells of eGFP transgenic female C57Bl/6J mice were stained with mouse anti-CD45/APC (BD Bioscience) and then sorted using FACS AriaIII (BD Bioscience, CA). Thirty six chronic liver injured mice were divided equally into two groups, sham control (ShC) and transplantation (Tx). ShC mice received normal saline and Tx group received 5 million sorted CD45 + cells through intrasplenic route.
In chronic injury model, the purpose of using high cell dose was for repair (resolution of fibrosis) and liver regeneration; whereas, in case of acute injury low cell dose was used as they were required only for liver regeneration. In fibrotic liver, the collagenous scar is mainly degraded by MMPs secreted from monocytes/macrophages (CD11b) and neutrophils (Ly6g) (~ 55% of CD45 + BM cells). In separate experiments, three more groups of fibrotic mice were used; in the first group (n = 3) each mouse received same cells (CD45) as before, in second group (n = 3) 3 million CD45
+/-cells and in third group (n = 3) of mice 2 million CD45 + CD11b -
Ly6g
-cells were transplanted.
Supporting methods
Other methods, including liver perfusion, isolation of hepatocytes, phenotypic characterization of cells, TUNEL assay, FISH, liver function tests, reverse transcriptase polymerase chain reaction, primer design (Table 1 ), etc. are described.
Statistics
Results of multiple experiments were reported as mean ± SEM (Standard Error Mean). Student's t-test was carried out to calculate the significance between the means of both groups and p value < 0.05 was considered as significant. All analyses were carried out using Graph pad Prism software, Version 5.02.
Results

Recovery of liver function depends on the nature and the extent of injury
A single dose (500 mg/kg body weight) of acetaminophen led to centrilobular necrosis of the liver, which healed considerably within 4 days ( Figure 1A , top panel). These changes in liver pathology were coupled with steep rise in serum ALT levels, which later declined towards the normal level as liver regeneration progressed ( Figure  1B) . In chronic injury model, gross tissue necrosis was not observed even after 10 weeks of CCl 4 administration, instead putative fibrotic Figure 1A , bottom panel, right image) with higher levels of serum ALT compared to healthy control ( Figure 1C ).
CD45 cell therapy improves liver fibrosis
CCl 4 -induced liver fibrosis model was adopted to study the effect of donor derived CD45 + cells in case of chronic injury. Each mouse was transplanted with 5 × 106 syngeneic GFP-expressing CD45 + cells that were phenotypically highly heterogeneous, consisting of progenitors and committed hematopoietic cells (Supporting Figure  1A and Supporting Figure 1B ) through intrasplenic route after 10 weeks of CCl 4 administration, and mice were sacrificed at different time periods to assess the resolution of fibrosis. Almost complete regression of fibrosis had occurred within 90 days of transplantation as evidenced in the picrosirius red and α-SMA stained liver sections, whereas natural regression in sham control (ShC) mice was much slower (Figure 2A ). Interestingly, steady and significant drop of CPA by about 25% was observed in the Tx group within 15 days even under pro-fibrotic conditions, indicating that transplantation of CD45 cells resulted in improved clearance of collagen when compared with ShC ( Figure 2B ). Furthermore, transplantation of CD45 cells showed improving trend of liver function as sera ALT levels were declined as compared to ShC group (Supporting Figure 2) . In contrast, no improvements of sera bilirubin and albumin levels were observed due to transplantation of cells, except for 3 months samples (Supporting Figure 2 ). According to these results the effect of the cell transplant seems to exert an acceleration of the natural process of restoration of the liver condition after withdrawal of CCl 4 dose.
Activated hepatic stellate cells (HpSCs) which secrete excess collagen in response to chronic injury, measured in terms of SMAexpressing cells (area) were also significantly (p < 0.01, 0.001) reduced in transplanted mice as compared with ShC mice, indicating that CD45 + cells were either involved in deactivating the activated HpSCs or inducing their apoptosis or both ( Figure 2A and Figure 2C ).
As about 60% of donor cells were composed of monocytes/ macrophages and neutrophils, we propose that enhanced recovery of liver from fibrosis was due to the effect of MMPs secreted by these cells. Tissue level gene expression analysis showed that except for MMP2, the expressions of MMP9, 12, 13 were significantly (p < 0.05, 0.01, n = 2 for each time point) increased post 7 and 15 days of CD45 transplantation when compared with corresponding ShC groups ( Figure 3A ).
To know the subset of CD45 + cells that was primarily responsible for regression of fibrosis, we divided transplant into two fractions: CD45 
Ly6g
+/-cells were found to be significantly (p < 0.01) more fibrolytic.
Another interesting observation was a significant reduction of apoptosis in both hepatocytes and non-parenchymal cells due to transplantation of CD45 cells. In pro-fibrogenic condition, the transplantation of CD45 cells led to significant decline of TUNEL + hepatocytes as compared with ShC mice (17.69 ± 3.43% versus 40.0 ± 3.29% per 600 × field, p < 0.05, n = 2) (Figure 4 ). Despite significant recovery apoptotic cells were present in Tx group, this was possible due to the effect of CCl 4 treatment as it was discontinued just 3 days prior to this analysis.
BM-derived stem/progenitor cells are involved in liver regeneration
To examine whether BM cells have any role in liver regeneration, we transplanted Lin -cells in acute liver injured mice, whereas the chronic To find out whether CD45 cells transplantation led to activation of HPCs, we analyzed liver sections after 7 days of transplantation. Interestingly, ductular reaction was found to be relatively high in Tx group as EpCAM/CK-19 expressing cells were detected, but it was not significantly higher than ShC group ( Figure 5C ). Figure 6E ). These results were supported by X,Y chromosome FISH analysis, confirming that the Y-chromosome in GFP + cells were under 6% ( Figure 6F and Figure 6G ). Low percentage of XY-chromosome bearing BM-derived hepatic cells in livers of both damaged models indicated that the fusion heterokaryons, if any, might have divided into host and donor-derived hepatocytes and maintained their sex chromosomal status.
Discussion
BM cell therapy has been found to be a promising treatment option for many liver diseases. Earlier reports suggested that under strong selection pressure, as in case of Fah -/-model, BM-derived hepatocytes, a putative product of fusion heterokaryons, can rapidly proliferate and replace the damaged/mutated host cells [7] . Heterokaryons are fairly unstable, during reductive division the abnormal chromosomal segregation may lead to neoplasia [20] . In this study, using acute and chronic liver injury models we have shown the presence of BM-
Molecular analysis of donor-derived hepatocytes
During lineage conversion to hepatic phenotype, partial nuclear reprogramming of BM cells is expected to occur. Real time RT-PCR analysis of BM-derived hepatocytes showed that pan-hematopoietic (CD45) and stem cell antigen (Sca-1) genes were completely silenced, whereas expression of transcription factor Gata2 was significantly down regulated in BM-derived hepatocytes ( Figure 6A ). Donor-derived hepatic cells in acute injury model did not express stemness genes such as Oct4, Sox2 and Nanog ( Figure 6B ). To study oncogenic transformation of the cells, we then conducted analyses of cell cycle and hepatocellular carcinoma (HCC) marker genes. The expression of c-Myc was marginally increased in these cells as compared to primary hepatocytes, whereas Cyclin D2 and p21 expressions were comparable ( Figure 6C ). Interestingly, HCC marker α-fetoprotein was not expressed in these cells ( Figure 6C ). Similar trend of gene expressions (tissue level) were also observed in case of chronic liver injury model (Supporting Figure 4A and Supporting Figure 4B ). Above preliminary results indicate that nuclear reprogramming of BM-derived cells did not led to oncogenic transformation.
To investigate X,Y chromosomal status in BM-derived hepatic derived hepatocytes till the end of the experiments. Interestingly, these neo hepatocytes present in host liver were found free from many genes associated with neoplasia.
The purpose of using two different preparations of cells in acute and chronic injury model was that liver fibrosis prevails in the later case. Our earlier report showed CD45 + BM cells have better anti-fibrotic effects than mesenchymal stem cells [21] . Since monocytes/ macrophages and neutrophils have distinct roles in resolution of fibrosis through the secretion of MMP-9 and 13 [ ) additively contributes to the recovery of liver from fibrosis. The gradual decline of aHpSCs in Tx mice was probably due to apoptotic stimuli from the activated macrophages and KCs [24] or natural deactivation process mediated by progenitor cells present in CD45 + CD11b -
Ly6g
-fraction.
Between the two models examined, chronic liver injury showed 3-fold more BM-derived hepatocytes than the acute injury model. In chronic injury model, intrasplenic transplantation allowed direct cell delivery to the liver and subsequent engraftment of major fraction of the competent cells. During chronic injury, liver was repeatedly injured with CCl 4 , which lead to continuous degeneration and regeneration allowing slow but steady incorporation of BM-derived cells during the regeneration process, so a higher level of chimerism was detected. On the other hand, systemic route was followed to deliver cells in case of acute injury model leading to wide distribution throughout the body and relatively less number of cells homing to the liver. Again, adult liver can regenerate at earliest on its' own as the mature hepatocytes can extensively proliferate [25] . Due to this brief regeneration period, the donor-derived cells may not play a major role in liver regeneration. Our earlier studies and the reports from other groups supported this moderate level of liver chimerism by BM cells in case of acute injury [26] [27] [28] .
Down-regulation or silencing of hematopoietic genes in the recipient liver after phenotype change suggested partial nuclear programming [29] . Pluripotent genes (Oct4, Sox2, and Nanog) are generally expressed in embryonic stages of mammals; these are also shown to be expressed in carcinomas, including HepG2 cell line [30, 31] . Lack of expressions of these genes in neo hepatocytes or in recipient tissue (chronic injury) suggested that nuclear reprogramming of BM cells in these present experimental models did not activate these genes. G1/S cyclins (cyclin D2 and E2) were found to be negatively regulated by miR-26a, thereby control cell growth [32] . CDK inhibitor p21, a target of miR-106b and miR-93, was found to be over expressed in HCC [33] . Absence of p21 gene expression further suggests neoplastic transformation did not occur in BM-derived hepatocytes after partial reprogramming. c-Myc, a protooncogene, has been implicated as a regulator of hepatocyte proliferation and metabolic functions [34, 35] . As an early gene, c-Myc expression has been reported to be induced following partial hepatectomy, and is a key factor in the transcriptional response leading to the progression of hepatocytes from G0/G1 to S phase [36] . Relatively high expression of c-Myc in BM-derived hepatocytes was probably due to their immaturity and proliferation status as compared to adult primary hepatocytes.
Heterotypic cell fusion between donor BM cells and host hepatocytes can generate either a synkaryon produced by the merging of nuclei or a binucleated heterokaryon in the absence of nuclear fusion. Irrespective of the partial nuclear reprogramming that might have occurred in one of the fusion partners (BM-derived hepatocytes), we could not detect numerous fused cells in eGFP + fraction of hepatocytes post 3 months of transplantation, as determined by the alternate methods. Even though BM-derived hepatocytes were formed due to cell fusion, we predict that the ploidy status in both cell types was restored due to a combination of cellular proliferation, fusion, and reductive division [37] . The other aspect of this study was that in spite of cell fusion that used to be the principle mechanism of phenotype conversion, we detected only a few donor-derived hepatocytes that possessed Y chromosome. This still puts forth the question as to the origin of the remaining BM derived hepatocytes. Overall, our study shows the significance of BM cell therapy in resolution of fibrosis and liver regeneration. Furthermore, the preliminary molecular analyses do not reveal any genetic changes in the BM-derived hepatocytes that may lead to neoplasia. In clinical translation, BM cell therapy would be an ideal approach to treat many liver diseases, which warrants detailed investigation.
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Supporting Methods
Animals: Six to eight-week-old male C57BL/6J and eGFP transgenic mice [C57BL/6-Tg(UBC-GFP) 30 Scha/J] were used in this investigation. Mice were obtained from Jackson Laboratories (Bar Harbor, ME) and maintained in an experimental animal facility in our institute. Mice were kept in IVC and fed with autoclaved acidified water and irradiated food ad libitum.
Flow cytometry: BM CD45
+ cells were analyzed for different phenotypes, such as B220, CD3, CD34, CD11b, Ly6g-expressing cells using specific antibodies (BD Pharmingen) and FACS AriaIII (BD Bioscience, CA).
Isolation of hepatocytes and purity: Hepatocytes were isolated by two-stage perfusion method. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg), both were purchased from Helpro Health Product, Pune, India. In step I, the liver was perfused with 30 ml of Ca 2+ /Mg 2+ ionfree HBSS buffer containing 0.5 mM EGTA, 25 mM HEPES at 37 ºC for 15 min, all were purchased from Sigma-Aldrich, St. Louise. In the step II, 30 ml of the same buffer, lacking EGTA, but containing 0.03% collagenase I (Sigma-Aldrich, St. Louise) and 5 mM CaCl 2 (SigmaAldrich, St. Louise) was used for perfusion. The liver capsule was incised and single-cell suspension was prepared in RPMI-1640 (Gibco, New York) containing 10% FBS (Biological Industries, Kibbutz BeitHaemek, Israel) and separated through 100 µm cell strainer. Cell suspension was centrifuged at 50 g for 5 minutes to isolate hepatocytes from non-parenchyma cells, the pellet was washed two-times in the same medium. Donor and host hepatocytes were sorted on the basis of GFP expression. The sorted donor cells were then analyzed by immunocytochemistry on the basis of the expressions of albumin and GFP. Samples with > 96% cells expressing both GFP and albumin were considered as homogeneous preparation and used for the subsequent experiments.
Absolute quantification of SRY gene and XY chromosome FISH: We followed a sex-mismatched transplantation model where donor cells from female eGFP mice were transplanted into male non-eGFP mice. Absolute quantification of the Sry gene was carried out in GFP + and GFP -hepatocytes by real time qPCR (Stratagene MxPro 3000, Agilent Technologies, Santa Clara, CA) using SYBR green (Fermentas, Massachusetts) chemistry. Standards for Sry gene were prepared by mixing known numbers of female (XX) and male (XY) hepatocytes at different dilutions (100%, 75%, 50% 25%, 10%, 1%, 0.1%, 0.01%, 0.001% and 0% of Y chromosome containing cells) corresponding to the percentage fusion. Genomic DNA (gDNA) was isolated by kit (Fisher Scientific, Canada) from the standard cell mixtures and sorted GFP + /GFP -hepatocytes. The same quantity of gDNA (100 ng) for each template was used for the PCR of Sry and β-actin genes. The Ct values of sorted samples were fit in the standard curve generated, and their percentage fusion was determined.
X,Y FISH was conducted on the basis on our earlier publication. In brief, fixed and denatured nuclei were reacted with wholechromosome paint probes Poseidon™ RAB9B (XqF1) / WC Y mouse probe (Kreatech Diagnostics, Amsterdam, Netherlands) to detect X chromosome labeled with Platinum Bright™ 550 and Y chromosome labeled with Platinum Bright™ 495. The DAPI stained nuclei were visualized and scored using an upright Olympus BX51 fluorescence microscope (1000 ×). CytoVision TM and Genus TM imaging software (Applied Imaging, CA) were used to capture the images.
Gene expression: Total RNA was isolated from embryonic liver, ID8 cell line, primary hepatocytes (GFP -) and sorted GFP + hepatocytes using TRIzol Reagent (Invitrogen, Carlsbad, CA) according to manufacturer's instructions, and cDNA was synthesized using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CA). Real-time PCR was performed using SYBR green technology in a Stratagene Mx3000P QPCR System (Agilent, CA). The primers used for the PCR were synthesized from Sigma Life Science, Bangalore, India. The sequences of primers are provided in the table 1.
Apoptosis: Apoptotic cells were identified by TUNEL assay (Promega Corporation Madison, WI). In brief, paraffin embedded liver sections were stained for albumin. The TUNEL assay reagent was added on sections and incubated at 37 o C for 1 h. Reaction was terminated with 2× SSC buffer, nuclei stained with DAPI and visualized under microscope.
Immunohistochemical analyses: Fixed cells and liver sections were stained with the respective antibodies. The sections or cells were observed under an Olympus fluorescence microscope and images were captured and acquired by DP70 digital camera (Model IX51, Olympus, Tokyo, Japan) using LCPlanFl 20 × and 60 × objectives by Image Pro software. The images were composed and edited in Photoshop 6.0 (Adobe). Antibodies used for IHC analysis were antimouse α-SMA (Imgenex, Bhubaneswar, India), anti-mouse eGFP (Clontech-Takara Bio Company, Kyoto, Japan), anti-mouse albumin (Bethyl, Montgomery, Texas), anti-mouse Ki67, anti-EpCAM (Abcam, Cambridge, UK), anti-HNF4α and anti-CK19 (Santa Cruz Biotechnology, Santa Cruz, CA). The secondary antibodies used were donkey anti-mouse Alexafluor 488, donkey anti-goat Alexafluor 594, donkey anti-rabbit Alexafluor 594, all of them were procured from Molecular Probes Inc, Eugene.
Liver function tests: Sera ALT, bilirubin and albumin levels were quantified by spectrophotometric methods, using commercially available kits (Transasia Bio-medicals Ltd, New Delhi, India). (A) Pluripotent (Sox2, Oct4, Nanog) and HCC related (AFP) gene expression in liver tissue of chronic liver injured mice after 3 months of CD45 + transplantation by qPCR. As controls, fetal tissue and normal adult hepatocytes were used. * denotes no Ct value; (B) Quantitative RT-PCR analyses of cell cycle genes in three months post-transplanted samples. ID8 tumor cell line was used as positive control. Number of mice in each group = 3.
